Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
9/05 | 6,800 USD
+5,43% |
+5,43% |
C4X Discovery Holdings plc |
25/04 | 12,000 GBX
+27,32% |
+27,32% |
|
Cabaletta Bio Inc |
9/05 | 12,220 USD
+1,16% |
+1,16% |
|
Calithera Biosciences Inc |
6/05 | 0,020 USD
0,00% |
0,00% |
|
Calliditas Therapeutics AB |
9/05 | 20,330 USD
-1,13% |
-1,13% |
|
Cambridge Cognition Holdings plc |
9/05 | 48,000 GBX
-1,03% |
-1,03% |
|
Can B Corp |
9/05 | 0,027 USD
-7,02% |
-7,02% |
|
Can-Fite Biopharma Ltd |
9/05 | 2,142 USD
+6,03% |
+6,03% |
|
Capricor Therapeutics Inc |
9/05 | 5,420 USD
+0,93% |
+0,93% |
|
Cara Therapeutics Inc |
9/05 | 0,760 USD
+3,68% |
+3,68% |
Carbios |
9/05 | 23,500 EUR
+2,40% |
+2,40% |
Cardiol Therapeutics Inc - Class A |
9/05 | 3,030 CAD
+10,18% |
+10,18% |
|
Cardiovascular Systems Inc. |
27/04 | 20,000 USD
+0,15% |
+0,15% |
|
Caredx Inc |
9/05 | 11,060 USD
+8,64% |
+8,64% |
|
Carisma Therapeutics, Inc. |
9/05 | 1,510 USD
-2,58% |
-2,58% |
|
Carmat |
9/05 | 4,320 EUR
+6,14% |
+6,14% |
|
CASI Pharmaceuticals Inc |
9/05 | 2,623 USD
-0,64% |
-0,64% |
|
Cassava Sciences Inc |
9/05 | 21,110 USD
-2,13% |
-2,13% |
|
Castle Biosciences Inc |
9/05 | 24,420 USD
+3,74% |
+3,74% |
|
Catalent Inc. |
9/05 | 55,980 USD
-0,39% |
-0,39% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
|
Catalyst Pharmaceuticals Inc |
9/05 | 15,650 USD
+6,32% |
+6,32% |
|
Ceapro Inc. |
9/05 | 0,255 CAD
+2,00% |
+2,00% |
|
Cel-Sci Corp. |
9/05 | 1,510 USD
+8,63% |
+8,63% |
|
Celldex Therapeutics Inc. |
9/05 | 41,060 USD
-0,36% |
-0,36% |
|
Cellectar Biosciences Inc |
9/05 | 3,240 USD
+1,25% |
+1,25% |
|
Cellectis |
9/05 | 2,820 EUR
+0,71% |
+0,71% |
|
Cellectis |
9/05 | 3,240 USD
+4,52% |
+4,52% |
Celyad Oncology |
9/05 | 0,319 EUR
+5,11% |
+5,11% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
|
Cerus Corp. |
9/05 | 1,910 USD
+1,60% |
+1,60% |
|
Champions Oncology Inc |
9/05 | 4,960 USD
+2,06% |
+2,06% |
|
Charlottes Web Holdings Inc |
9/05 | 0,230 CAD
-9,80% |
-9,80% |
|
Check-Cap Ltd |
9/05 | 2,220 USD
0,00% |
0,00% |
|
Checkpoint Therapeutics Inc |
9/05 | 1,560 USD
-3,70% |
-3,70% |
|
Chembio Diagnostics Inc. |
27/04 | 0,455 USD
+0,22% |
+0,22% |
|
Chimerix Inc |
9/05 | 1,010 USD
+4,06% |
+4,06% |
|
China Pharma Holdings Inc. |
9/05 | 0,311 USD
+0,39% |
+0,39% |
|
China SXT Pharmaceuticals Inc |
9/05 | 1,080 USD
-3,57% |
-3,57% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
9/05 | 12,600 USD
-3,45% |
-3,45% |
|
Cipher Pharmaceuticals Inc |
9/05 | 8,950 CAD
-1,97% |
-1,97% |
|
Citius Pharmaceuticals Inc |
9/05 | 0,701 USD
+5,70% |
+5,70% |
|
Clean Air Metals Inc |
9/05 | 0,050 CAD
0,00% |
0,00% |
|
ClearPoint Neuro Inc |
9/05 | 6,110 USD
+2,00% |
+2,00% |
|
Clearside Biomedical Inc |
9/05 | 1,350 USD
+6,30% |
+6,30% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Cns Pharmaceuticals Inc |
9/05 | 0,209 USD
-12,92% |
-12,92% |
|
Co-Diagnostics Inc |
9/05 | 1,230 USD
+0,82% |
+0,82% |
|
Cocrystal Pharma Inc |
9/05 | 1,750 USD
+9,03% |
+9,03% |
|
Codiak Biosciences Inc |
4/04 | 0,057 USD
0,00% |
0,00% |
|
Cogent Biosciences Inc |
9/05 | 7,920 USD
+4,21% |
+4,21% |
|
CohBar Inc |
9/05 | 0,760 USD
-5,11% |
-5,11% |
|
Coherus Biosciences Inc |
9/05 | 2,120 USD
-4,93% |
-4,93% |
|
Collegium Pharmaceutical Inc |
9/05 | 37,860 USD
-0,53% |
-0,53% |
|
CollPlant Biotechnologies Ltd |
9/05 | 6,750 USD
+8,17% |
+8,17% |
Coloplast |
8/05 | 845,200 DKK
+0,33% |
+0,33% |
|
Compass Pathways Plc |
9/05 | 8,540 USD
+0,47% |
+0,47% |
|
Compass Therapeutics Inc |
9/05 | 1,590 USD
+0,63% |
+0,63% |
|
Compugen Ltd. |
9/05 | 2,090 USD
-1,88% |
-1,88% |
|
Concert Pharmaceuticals Inc |
4/04 | 8,370 USD
0,00% |
0,00% |
|
Condor Technologies |
29/02 | 12,000 EUR
-4,00% |
-4,00% |
|
Conformis Inc. |
1/09 | 2,260 USD
0,00% |
0,00% |
|
Conmed Corp. |
9/05 | 70,340 USD
+1,35% |
+1,35% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Convatec Group |
9/05 | 261,800 GBX
+0,23% |
+0,23% |
|
Cooper Companies, Inc. |
9/05 | 94,690 USD
+2,94% |
+2,94% |
|
Cooper Companies, Inc. |
9/05 | 94,690 USD
+2,94% |
+2,94% |
|
Corbus Pharmaceuticals Holdings Inc |
9/05 | 43,740 USD
+3,18% |
+3,18% |
|
Corcept Therapeutics Inc |
9/05 | 26,600 USD
+4,72% |
+4,72% |
|
CorMedix Inc |
9/05 | 5,410 USD
-5,17% |
-5,17% |
|
Corvus Pharmaceuticals Inc |
9/05 | 2,030 USD
+3,57% |
+3,57% |
|
Covalon Technologies Ltd. |
9/05 | 1,090 CAD
+2,83% |
+2,83% |
|
Creo Medical Group Plc |
9/05 | 34,750 GBX
-99,00% |
-99,00% |
|
Crescita Therapeutics Inc |
9/05 | 0,435 CAD
0,00% |
0,00% |
|
Crinetics Pharmaceuticals Inc |
9/05 | 49,420 USD
-2,89% |
-2,89% |
|
CRISPR Therapeutics AG |
9/05 | 53,550 USD
+0,49% |
+0,49% |
|
Cronos Group Inc |
9/05 | 2,850 USD
+10,47% |
+10,47% |
|
Crossject |
9/05 | 2,110 EUR
-2,31% |
-2,31% |
|
Cryo-Cell International, Inc. |
9/05 | 9,000 USD
+2,97% |
+2,97% |
|
CTI BioPharma Corp |
23/06 | 9,090 USD
0,00% |
0,00% |
|
Cue Biopharma Inc |
9/05 | 1,915 USD
+0,26% |
+0,26% |
|
Cumberland Pharmaceuticals Inc. |
9/05 | 1,740 USD
+4,19% |
+4,19% |
|
CureVac N.V. |
9/05 | 2,980 USD
+3,47% |
+3,47% |
|
Curis Inc |
9/05 | 16,510 USD
+0,98% |
+0,98% |
|
Cutera Inc |
9/05 | 2,340 USD
-6,77% |
-6,77% |
|
Cyanotech Corp. |
9/05 | 0,335 USD
+15,34% |
+15,34% |
|
Cyclacel Pharmaceuticals Inc |
9/05 | 2,310 USD
-0,43% |
-0,43% |
|
Cyclacel Pharmaceuticals Inc |
9/05 | 6,300 USD
0,00% |
0,00% |
|
Cyclerion Therapeutics Inc |
9/05 | 3,000 USD
+4,60% |
+4,60% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
9/05 | 64,020 USD
-1,92% |
-1,92% |
|
CytomX Therapeutics Inc |
9/05 | 2,040 USD
-51,31% |
-51,31% |
|
Cytosorbents Corp |
9/05 | 0,810 USD
-7,10% |
-7,10% |
Cytotools AG |
9/05 | 0,406 EUR
-0,49% |
-0,49% |